“…These risk genes/polymorphisms are involved in a series of biological processes, including the regulation of cholesterol (e.g., ApoE, CETP) (Nebes et al, 2001;Hogh et al, 2007;Godin et al, 2009;Paternoster et al, Brought to you by | Carleton University OCUL Authenticated Download Date | 6/18/15 3:37 AM 2009; Qureischie et al, 2009), the regulation of systemic blood pressure and cerebral blood flow (e.g., ACE, AGT, AGTR1, CYP11B, F3) (Amar et al, 1998;Schmidt et al, 2001;Verpillat et al, 2001;Hassan et al, 2002;Henskens et al, 2005;van Rijn et al, 2007;Smith et al, 2009;), the biosynthesis of DNA and RNA (e.g., MTHFR) (Kohara et al, 2003;Linnebank et al, 2009;Hong et al, 2009;Szolnoki et al, 2012), immune response and inflammation (e.g., IL-6, IL5RA, ITGB6, CAPN10, NR3C1, KITLG) (Fornage et al, 2008;van Rossum et al, 2008;Smith et al, 2009;Fernandez-Cadenas et al, 2011), neuron regeneration (e.g., BDNF) (Taylor et al, 2008), neuroinflammation (e.g., MMP2, MMP3, MMP9, MMP13) (Fornage et al, 2007;Smith et al, 2009;Fernandez-Cadenas et al, 2011), cystoskeleton and cell adhesion (e.g., KNS2, ADD1, A2M, ICAM1) (van Rijn et al, 2006;Szolnoki et al, 2007;Fernandez-Cadenas et al, 2011;Fornage et al, 2011), and oxidative stress (e.g., PON1, NOS3) (Schmidt et al, 2000a;Henskens et al, 2005;Hadjigeorgiou et al, 2007;Fernandez-Cadenas et al, 2011). Although these risk genes/polymorphisms were shown to be strongly associated with the increased risk of LA, th...…”